These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 23135000)
1. The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial. Xing C; Xu A J Drugs Dermatol; 2012 Oct; 11(10):e52-4. PubMed ID: 23135000 [TBL] [Abstract][Full Text] [Related]
2. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. Kumaran MS; Kaur I; Kumar B J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885 [TBL] [Abstract][Full Text] [Related]
3. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo. Newman MD; Silverberg NB Cutis; 2011 Nov; 88(5):256-9. PubMed ID: 22272490 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905 [TBL] [Abstract][Full Text] [Related]
5. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial. Kircik LH J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509 [TBL] [Abstract][Full Text] [Related]
6. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812 [TBL] [Abstract][Full Text] [Related]
7. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp. McCormack PL Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117 [TBL] [Abstract][Full Text] [Related]
8. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris. Fleming C; Ganslandt C; Leese GP J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and local safety of a calcipotriol/ betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris. Parslew R; Traulsen J Eur J Dermatol; 2005; 15(1):37-9. PubMed ID: 15701591 [TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol. Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256 [TBL] [Abstract][Full Text] [Related]
11. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141 [TBL] [Abstract][Full Text] [Related]
12. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp. Kragballe K; van de Kerkhof P J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():10-21. PubMed ID: 24684739 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of simple onycholysis: an open-label study. Park JM; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim BS; Kim MB J Am Acad Dermatol; 2013 Sep; 69(3):492-3. PubMed ID: 23957979 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259 [TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial. Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049 [TBL] [Abstract][Full Text] [Related]
16. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial. Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334 [TBL] [Abstract][Full Text] [Related]
17. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. van de Kerkhof PC Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355 [TBL] [Abstract][Full Text] [Related]
18. Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study. Vena GA; Galluccio A; Pezza M; Vestita M; Cassano N J Dermatolog Treat; 2012 Aug; 23(4):255-60. PubMed ID: 21756153 [TBL] [Abstract][Full Text] [Related]
19. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort. van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129 [TBL] [Abstract][Full Text] [Related]
20. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]